FDA rejects oleandrin, an unproven coronavirus therapeutic pushed by MyPillow CEO, as a dietary supp
https://amp.cnn.com/cnn/2020/09/04/health/oleandrin-coronavirus-fda-mypillow/index.html
Jen Christensen and Jamie Gumbrecht, CNN
Updated 5:34 PM EDT, Fri September 04, 2020
CNN)The US Food and Drug Administration has rejected a submission from Phoenix Biotechnology Inc. to market oleandrin as a dietary supplement ingredient, citing "significant concerns" about the safety evidence the company presented.
Last month, MyPillow CEO Mike Lindell, who recently joined the board of Phoenix Biotechnology and has a financial stake in the company, said he had participated in a July meeting at the White House with President Donald Trump regarding the use of oleandrin as a potential therapeutic for the coronavirus.
The extract comes from the Nerium oleander plant; the raw oleander plant is highly toxic and consuming it can be fatal. There are no peer-reviewed, published studies on the impact of oleandrin on Covid-19, and there's no public evidence it has been studied in patients with Covid-19.
More at link.